Page last updated: 2024-11-04

sulfasalazine and Biliary Tract Diseases

sulfasalazine has been researched along with Biliary Tract Diseases in 1 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Biliary Tract Diseases: Diseases in any part of the BILIARY TRACT including the BILE DUCTS and the GALLBLADDER.

Research Excerpts

ExcerptRelevanceReference
" Plasma and urine concentrations of 5-AS and its acetylated major metabolite (AcAS) were monitored during one dosing interval."2.65Disposition of 5-aminosalicylic acid, the active metabolite of sulphasalazine, in man. ( Fischer, C; Klotz, U; Maier, K; Stumpf, E; von Gaisberg, U, 1983)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fischer, C1
Maier, K1
Stumpf, E1
von Gaisberg, U1
Klotz, U1

Trials

1 trial available for sulfasalazine and Biliary Tract Diseases

ArticleYear
Disposition of 5-aminosalicylic acid, the active metabolite of sulphasalazine, in man.
    European journal of clinical pharmacology, 1983, Volume: 25, Issue:4

    Topics: Adult; Aged; Aminosalicylic Acids; Bile; Biliary Tract Diseases; Colitis, Ulcerative; Crohn Disease;

1983